Showing results (1211-1220 of 1,231) with videos related to

Sort By:
Pageof 124
Transplantation|July 26, 2019
Perceptions and Practices Regarding Frailty in Kidney Transplantation: Results of a National SurveyMara A McAdams-DeMarco, Sarah E Van Pilsum Rasmussen, Nadia M Chu, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Open Forum Infectious Diseases|June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIVGrace L Kulik, Triin Umbleja, Todd T Brown, et al.
Neurosurgery|July 28, 2021
A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary GlioblastomaAdham M Khalafallah, Maureen Rakovec, Chetan Bettegowda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2025
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE TrialMichael J Corley, Maya Watanabe, Alina P S Pang, et al.
AIDS (London, England)|July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIVKristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
The Lancet. HIV|April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysisTriin Umbleja, Mohammad U Zafar, Sara McCallum, et al.
JACC. Advances|August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIVKristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
AIDS (London, England)|November 11, 2025
Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE TrialMarissa R Diggs, Sarah M Chu, Kathleen V Fitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2025
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIVSteven K Grinspoon, Maya Watanabe, Heather J Ribaudo, et al.
Pageof 124